DOP034: Assessment of direct healthcare cost drivers of Crohn’s disease in a Dutch population-based cohort study shows a major shiftECCO '18 Vienna
2018
DOP035: Beclomethasone dipropionaat is effective for microscopic colitis: results of an open-label multicentre study (COLCO)ECCO '18 Vienna
2018
DOP036: Ustekinumab for Crohn’s disease: a nationwide real-life observational cohort study (ICC case series)ECCO '18 Vienna
2018
DOP039: Exploring stoma rates in Crohn’s disease in the biologic era: a population-based time trend analysisECCO '18 Vienna
2018
DOP041: Surgery and hospitalisation in patients with inflammatory bowel disease; 10-year follow-up of a Danish population-based inception cohortECCO '18 Vienna
2018
DOP042: Need for ileocaecal resections, but not ileo-colic re-resections, has decreased: a nationwide study of temporal trends in Crohn surgery in Sweden 1990–2014ECCO '18 Vienna
2018
DOP043: Comparative outcomes of ileal pouch revision vs. excision for pouch failure within the American College of Surgeon National Surgical Quality Improvement ProgrammeECCO '18 Vienna
2018
DOP046: Higher serum concentrations of vedolizumab are associated with superior endoscopic outcomes in Crohn’s disease: data from the LOVE-CD trialECCO '18 Vienna
2018
DOP047: Infliximab exposure predicts superior endoscopic outcomes in patients with active Crohn’s disease: pharmacokinetic–pharmacodynamic analysis of TAILORIXECCO '18 Vienna
2018
DOP048: Vedolizumab levels during induction are associated with long-term clinical and endoscopic remission in patients with inflammatory bowel diseaseECCO '18 Vienna
2018
DOP049: Combination therapy of cyclosporine and vedolizumab is effective and safe for severe, steroid-resistant ulcerative colitis patients: A prospective studyECCO '18 Vienna
2018
DOP050: Influence of disease location on vedolizumab efficacy in inflammatory bowel disease: a real-life multicentre experienceECCO '18 Vienna
2018
DOP051: Shorter disease duration is associated with higher response rates to vedolizumab in Crohn’s disease but not ulcerative colitis: a multi-centre consortium analysisECCO '18 Vienna
2018